Neurogenic contraction

Neurogenic contraction is a physiological process in which muscle tissue, typically smooth muscle, contracts in response to stimulation from innervating nerves rather than originating from within the muscle itself. This process is initiated by the arrival of an action potential at the nerve terminal, triggering the release of neurotransmitters such as acetylcholine, adenosine triphosphate (ATP), or norepinephrine into the synaptic cleft. These molecules then bind to specific receptors on the muscle cell membrane—primarily muscarinic (M3), purinergic (P2X1), or adrenergic (alpha-1) receptors—activating intracellular signaling pathways that lead to calcium influx and muscle shortening. In pharmacological research, neurogenic contractions are frequently studied using electrical field stimulation (EFS) in isolated tissue preparations to evaluate the potency and efficacy of drugs targeting the autonomic nervous system. While not a single molecular target, the individual receptors and transporters involved in this process serve as critical therapeutic targets for treating conditions such as overactive bladder, hypertension, and gastrointestinal motility disorders.

Other names

Nerve-mediated contractionNeurogenic responseEFS-induced contractionElectrically-evoked contraction

Inhibition of neuronal action potentials, blockade of neurotransmitter release, or antagonism of post-junctional receptors such as muscarinic, adrenergic, and purinergic receptors.